Evidence-based medicine (EBM) has been a very useful paradigm for assessing evidence in medicine. However, like any other framework, it can be misused, particularly when fundamentalist EBM methodolatry leads to its inappropriate application to questions for which it is ill-suited, a misuse that has been weaponized against public health during the pandemic.
Four years ago, I wrote about an essentially negative study looking at whether acupuncture could alleviate joint pain caused by aromatase inhibitors, a common treatment for estrogen-sensitive breast cancer. The study’s back, and it doesn’t look any more positive.
I argue that science-based medicine (SBM) is the best medicine. Unfortunately, SBM isn’t nearly as great when so many people can’t afford it.
Another large randomized controlled trial for ivermectin showed no efficacy for the early treatment of COVID-19. This is not a surprise to science-based medicine advocates. Here’s why the story of ivermectin shows that SBM isn’t just for “complementary and alternative medicine” (CAM) —and never was.
